Dr. Lowery is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7979 N Shadeland Ave
Ste 310
Castleton, IN 46250Phone+1 317-621-3780
Education & Training
- Duke University HospitalFellowship, Gynecologic Oncology, 2013
- San Antonio Uniformed Services Health Education ConsortiumResidency, Obstetrics and Gynecology, 2005 - 2009
- University of Arkansas For Medical Sciences College of MedicineClass of 2005
Certifications & Licensure
- IN State Medical License 2007 - 2025
- MI State Medical License 2015 - 2019
- DC State Medical License 2015 - 2018
- NC State Medical License 2010 - 2018
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- 131 citationsRandomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas ...Amanda N. Fader, Dana M. Roque, Eric R. Siegel, Natalia Buza, Pei Hui
Clinical Cancer Research. 2020-08-01 - 278 citationsRandomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Fact...Amanda N. Fader, Dana M. Roque, Eric R. Siegel, Natalia Buza, Pei Hui
Journal of Clinical Oncology. 2018-03-27 - 5 citationsDoes Routine Posttreatment PET/CT Add Value to the Care of Women With Locally Advanced Cervical Cancer?Neil T. Phippen, Laura J. Havrilesky, Jason C. Barnett, Chad A. Hamilton, Michael P. Stany
International Journal of Gynecological Cancer. 2016-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: